Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is looking at a drug called MK-7648A for non small cell lung cancer.
It is open to people:
with that has spread ()
and who haven’t had treatment for their advanced cancer
Recruitment start: 13 June 2022
Recruitment end: 26 April 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Samreen Ahmed
Merck Sharp & Dohme LLC
Last reviewed: 09 Aug 2023
CRUK internal database number: 18421